Literature DB >> 8598363

Reoxygenation after single irradiation in rodent tumors of different types and sizes.

R Murata1, Y Shibamoto, K Sasai, N Oya, T Shibata, T Takagi, M Abe.   

Abstract

PURPOSE: To investigate the variation of reoxygenation patterns after single irradiation in murine tumors of different types and sizes. METHODS AND MATERIALS: Whole-body single irradiation of 13 to 15 Gy was delivered to 10 mm RIF1 tumors of C3H/He mice, 22 mm SCCVII tumors of C3H/He mice, and 16 mm EMT6 tumors of Balb/c mice. Thereafter, changes in the hypoxic fraction with time were determined by the paired survival curve method. The data were compared with the results we had ++previously obtained with 10 mm SCCVII and 10 mm EMT6 tumors.
RESULTS: The hypoxic fraction at 1 h after the priming irradiation was 26% for 10 mm RIF1 tumors, 48% for 10 mm SCCVII tumors, and 100% for 10 mm EMT6 tumors. Thus, RIF1 and SCCVII tumors, both of which have few necrotic areas, showed rapid reoxygenation, whereas EMT6 tumors, which have large necrotic areas, reoxygenated slowly. Although the hypoxic fraction returned to the pretreatment level within 72 h in 10 mm SCCVII and 10 mm EMT6 tumors, it did not in 10 mm RIF1 tumors. In contrast, the patterns of reoxygenation were similar between 22 mm and 10 mm SCCVII tumors and between 16 mm and 10 mm EMT6 tumors.
CONCLUSION: The three tumors showed different patterns of reoxygenation. Tumors that have a low proportion of necrosis may reoxygenate rapidly. However, tumor size appeared to have less influence on the pattern of reoxygenation.

Entities:  

Mesh:

Year:  1996        PMID: 8598363     DOI: 10.1016/0360-3016(95)02155-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

1.  Spatiotemporal stability of Cu-ATSM and FLT positron emission tomography distributions during radiation therapy.

Authors:  Tyler J Bradshaw; Stephen Yip; Ngoneh Jallow; Lisa J Forrest; Robert Jeraj
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-03-28       Impact factor: 7.038

2.  Fractionated stereotactic radiotherapy for metastatic brain tumors that recurred after gamma knife radiosurgery results in acceptable toxicity and favorable local control.

Authors:  Akifumi Miyakawa; Yuta Shibamoto; Shinya Takemoto; Toru Serizawa; Shinya Otsuka; Tatsuo Hirai
Journal:  Int J Clin Oncol       Date:  2016-11-08       Impact factor: 3.402

3.  Chemoradiotherapy for localized extranodal natural killer/T-cell lymphoma, nasal type, using a shrinking-field radiation strategy: multi-institutional experience.

Authors:  Yukiko Hattori; Taro Murai; Hiromitsu Iwata; Kaoru Uchiyama; Mikio Mimura; Eriko Kato; Rumi Murata; Yuta Shibamoto
Journal:  Jpn J Radiol       Date:  2016-02-06       Impact factor: 2.374

4.  Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels.

Authors:  Hiroshi Harada; Masahiro Inoue; Satoshi Itasaka; Kiichi Hirota; Akiyo Morinibu; Kazumi Shinomiya; Lihua Zeng; Guangfei Ou; Yuxi Zhu; Michio Yoshimura; W Gillies McKenna; Ruth J Muschel; Masahiro Hiraoka
Journal:  Nat Commun       Date:  2012-04-17       Impact factor: 14.919

5.  Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy.

Authors:  Kotoha Tatekawa; Hiromitsu Iwata; Takatsune Kawaguchi; Satoshi Ishikura; Fumiya Baba; Shinya Otsuka; Akifumi Miyakawa; Maho Iwana; Yuta Shibamoto
Journal:  Radiat Oncol       Date:  2014-01-07       Impact factor: 3.481

6.  Detection of hypoxic cells in murine tumors using the comet assay: comparison with a conventional radiobiological assay.

Authors:  K Shibuya; K Sasai; X Xie; H Utsumi; T Shibata; M Hiraoka
Journal:  Jpn J Cancer Res       Date:  1999-08

7.  Therapeutic Effect of Hypofractionated Stereotactic Radiotherapy Using CyberKnife for High Volume Cavernous Sinus Cavernous Hemangiomas.

Authors:  Lichao Huang; Lu Sun; Weijun Wang; Zhiqiang Cui; Zizhong Zhang; Jiwei Li; Yao Wang; Jinyuan Wang; Xinguang Yu; Zhipei Ling; Baolin Qu; Long Sheng Pan
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

8.  Strategies To Assess Hypoxic/HIF-1-Active Cancer Cells for the Development of Innovative Radiation Therapy.

Authors:  Chan Joo Yeom; Lihua Zeng; Yuxi Zhu; Masahiro Hiraoka; Hiroshi Harada
Journal:  Cancers (Basel)       Date:  2011-09-15       Impact factor: 6.639

Review 9.  Radiobiology of radiosurgery for the central nervous system.

Authors:  Antonio Santacroce; Marcel A Kamp; Wilfried Budach; Daniel Hänggi
Journal:  Biomed Res Int       Date:  2013-12-29       Impact factor: 3.411

Review 10.  Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?

Authors:  Yuta Shibamoto; Akifumi Miyakawa; Shinya Otsuka; Hiromitsu Iwata
Journal:  J Radiat Res       Date:  2016-03-22       Impact factor: 2.724

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.